Atossa Genetics (ATOS)
(Delayed Data from NSDQ)
$1.39 USD
-0.01 (-0.71%)
Updated Sep 25, 2024 03:59 PM ET
After-Market: $1.38 -0.01 (-0.72%) 7:00 PM ET
2-Buy of 5 2
D Value B Growth F Momentum D VGM
Cash flow Statements
Fiscal Year End for Atossa Genetics Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -30.09 | -26.96 | -20.61 | -17.83 | -17.24 |
Depreciation/Amortization & Depletion | 0.02 | 0.01 | 0.02 | 0.05 | 0.05 |
Net Change from Assets/Liabilities | 1.52 | -0.60 | -1.16 | -0.11 | -0.79 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 7.61 | 6.79 | 5.27 | 6.32 | 8.85 |
Net Cash From Operating Activities | -20.94 | -20.76 | -16.47 | -11.57 | -9.13 |
Property & Equipment | -0.01 | -0.03 | -0.01 | -0.01 | -0.01 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | -4.70 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -0.01 | -4.73 | -0.01 | -0.01 | -0.01 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -1.48 | 0.00 | 113.88 | 38.57 | 11.34 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | -0.57 | -0.01 | 0.00 |
Net Cash from Financing Activities | -1.48 | 0.00 | 113.30 | 38.55 | 11.34 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -22.43 | -25.49 | 96.82 | 26.97 | 2.20 |
Cash at Beginning of Period | 111.00 | 136.49 | 39.66 | 12.69 | 10.49 |
Cash at End of Period | 88.57 | 111.00 | 136.49 | 39.66 | 12.69 |
Diluted Net EPS | -0.24 | -0.21 | -0.18 | -1.97 | -2.03 |
Fiscal Year End for Atossa Genetics Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -11.93 | -5.88 | -30.09 | -22.34 | -16.11 |
Depreciation/Amortization & Depletion | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 |
Net Change from Assets/Liabilities | 1.92 | 0.76 | 1.52 | -0.13 | -1.55 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 0.77 | 0.42 | 7.61 | 7.09 | 6.17 |
Net Cash From Operating Activities | -9.23 | -4.70 | -20.94 | -15.37 | -11.49 |
Property & Equipment | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.30 | 0.20 | -1.48 | -1.48 | 0.00 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 0.30 | 0.20 | -1.48 | -1.48 | 0.00 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -8.93 | -4.50 | -22.43 | -16.86 | -11.50 |
Cash at Beginning of Period | 88.57 | 88.57 | 111.00 | 111.00 | 111.00 |
Cash at End of Period | 79.64 | 84.07 | 88.57 | 94.14 | 99.50 |
Diluted Net EPS | -0.05 | -0.05 | -0.06 | -0.05 | -0.08 |